You are viewing the site in preview mode

Skip to main content

Advertisement

Contact Christy Goldsmith

From: Stereotactic ablative radiotherapy (SABR) as primary, adjuvant, consolidation and re-treatment option in pancreatic cancer: scope for dose escalation and lessons for toxicity

Contact corresponding author